PRESS RELEASE published on 05/04/2023 at 12:30, 2 years 10 months ago Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 05/03/2023 at 22:05, 2 years 10 months ago Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/02/2023 at 23:15, 2 years 10 months ago Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines
PRESS RELEASE published on 04/20/2023 at 22:05, 2 years 10 months ago Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
PRESS RELEASE published on 04/20/2023 at 13:30, 2 years 10 months ago Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
PRESS RELEASE published on 04/16/2023 at 17:00, 2 years 11 months ago Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following C
PRESS RELEASE published on 04/11/2023 at 13:00, 2 years 11 months ago Moderna Announces Clinical and Program Updates at 4th Vaccines Day
PRESS RELEASE published on 04/06/2023 at 23:00, 2 years 11 months ago MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melan
PRESS RELEASE published on 03/30/2023 at 13:00, 2 years 11 months ago Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
PRESS RELEASE published on 03/24/2023 at 12:30, 2 years 11 months ago Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
Published on 03/19/2026 at 07:30, 1 hour 51 minutes ago Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 2 hours 46 minutes ago Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 8 hours 16 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 9 hours 36 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 12 hours 21 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/19/2026 at 09:14, 7 minutes ago With JODY-W6, u-blox brings secure tri-band Wi-Fi™6E for industrial IoT
Published on 03/19/2026 at 09:05, 16 minutes ago Huawei announces expansion of Curve Pay contactless payments across HUAWEI WATCH devices
Published on 03/19/2026 at 09:05, 16 minutes ago “Lead Transformation – Generate Impact”: Lenzing Presents Its 2025 Annual and Sustainability Report
Published on 03/19/2026 at 09:01, 20 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 03/19/2026 at 08:45, 36 minutes ago Deezer et Sonos renouvellent et étendent leur partenariat stratégique
Published on 03/19/2026 at 08:45, 36 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 2 hours 21 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 2 hours 21 minutes ago bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient
Published on 03/19/2026 at 07:00, 2 hours 21 minutes ago Résultats annuels 2025 et nouvelle signature stratégique
